15 May 2024 - Health technology assessment guidance often recommends a 3% real annual discount rate, the appropriateness of which has received limited attention. 

This article seeks to identify an appropriate rate for high-income countries because it can influence projected cost effectiveness and hence resource allocation recommendations.

Read Value in Health Editorial